Products for clinical
use are a valued component of Ben Venue's business. They receive the same
treatment as full-scale production items.
Your clinical batch will:
-
Be produced according to cGMP
-
Receive the same full documentation that a production batch receives
-
Be produced on the same equipment, using the same validated processes as
a production batch
-
Be handled by the same personnel as a production batch
The only difference between clinical and production manufacturing at Ben
Venue is scale. Other contract manufacturers refer clinical manufacturing
to Ben Venue because of our willingness to do small-scale batches. Large
ethical pharmaceutical companies contract with Ben Venue to manufacture their
clinical batches because they lack the facilities for small-scale production.
Furthermore, we can provide end product more quickly than their internal
manufacturing.
We offer a wide range of batch sizes with fill volumes from 0.5mL to 100mL.
Stability testing can be performed on clinical products that we have produced.
We also can help you with labeling and final package designs.
Clinical Manufacturing at Ben Venue Laboratories
-
Product and Process Development
Pre-IND Clinical Manufacturing
-
For animal toxicity studies
For chemical stability studies
-
Typical batch size up to 1,000 units
-
IND Phase I
-
For efficacy testing
For dosage- range finding
-
For human safety studies
For drug stability studies
-
Typical batch size up to 5,000 units
-
IND Phase II
-
For expanded clinical studies
For investigation of specialized delivery systems
-
For finalization of dosage form for market
Typical batch size up to 10,000 units
-
IND Phase III
-
For expanded clinical studies
For final development of label claims
-
For final development of contra-indications
For additional supplies required for compassionate use
-
For process validation
Typical batch up to 100,000 units
-
NDA Submission
|